Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Non-cash Items: 2024-2025

Historic Non-cash Items for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $41.0 million.

  • Kura Oncology's Non-cash Items fell 13.14% to $41.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.0 million, marking a year-over-year decrease of 13.14%. This contributed to the annual value of $44.0 million for FY2024, which is N/A change from last year.
  • Per Kura Oncology's latest filing, its Non-cash Items stood at $41.0 million for Q3 2025, which was down 6.18% from $43.7 million recorded in Q2 2025.
  • Kura Oncology's 5-year Non-cash Items high stood at $49.4 million for Q1 2024, and its period low was $7.7 million during Q4 2024.
  • For the 2-year period, Kura Oncology's Non-cash Items averaged around $40.7 million, with its median value being $47.2 million (2025).
  • Data for Kura Oncology's Non-cash Items shows a maximum YoY fell of 13.14% (in 2025) over the last 5 years.
  • Kura Oncology's Non-cash Items (Quarterly) stood at $7.7 million in 2024, then dropped by 13.14% to $41.0 million in 2025.
  • Its Non-cash Items stands at $41.0 million for Q3 2025, versus $43.7 million for Q2 2025 and $47.2 million for Q1 2025.